Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Brain Tumor Pathology|May 21, 2022
Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case reportAyako Yamazaki, Yasuhito Arai, Kohei Fukuoka, et al.
Brain Tumor Pathology|April 22, 2023
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitorsNaoki Shinojima, Kazutaka Ozono, Haruaki Yamamoto, et al.
Brain Tumor Pathology|November 16, 2025
Histopathological evaluation of dopamine receptor D2 expression in symptomatic gonadotroph pituitary neuroendocrine tumors: a case series including a rare metastatic case responsive to a dopamine agonistKen Uekawa, Naoki Shinojima, Takahiro Yamamoto, et al.
Journal of Neuro-Oncology|March 3, 2019
Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumorsNozomi Matsumura, Sumihito Nobusawa, Junko Ito, et al.
Stem Cells (Dayton, Ohio)|May 14, 2015
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 PathwayAnwar Hossain, Joy Gumin, Feng Gao, et al.
Endocrine Journal|April 12, 2023
Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibodyAn Murai, Naoki Shinojima, Genki Ikuta, et al.
Autophagy|February 9, 2008
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3Hiroshi Aoki, Yasuko Kondo, Kenneth Aldape, et al.
Scientific Reports|June 25, 2026
Rural medical disparities in multimodal glioblastoma treatmentYasutomo Momii, Nobuhiro Hata, Hirotaka Fudaba, et al.
Neuro-Oncology|June 20, 2022
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomasAtsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, et al.
Neuro-Oncology|October 21, 2021
The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumorsHideo Nakamura, Hirokazu Takami, Takaaki Yanagisawa, et al.
Pageof 9